Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Prenyloxyphenylpropanoids as novel lead compounds for the selective inhibition of geranylgeranyl transferase I.

Epifano F, Curini M, Genovese S, Blaskovich M, Hamilton A, Sebti SM.

Bioorg Med Chem Lett. 2007 May 1;17(9):2639-42. Epub 2007 Feb 2. Erratum in: Bioorg Med Chem Lett. 2007 Oct 1;17(19):5492.

PMID:
17314046
2.

Inhibitors of protein: geranylgeranyl transferases.

El Oualid F, Cohen LH, van der Marel GA, Overhand M.

Curr Med Chem. 2006;13(20):2385-427. Review.

PMID:
16918362
3.

Farnesyl transferase inhibitors: mechanism of action, translational studies and clinical evaluation.

Bishop WR, Kirschmeier P, Baum C.

Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S96-104. Review. No abstract available.

PMID:
14508086
4.

Turning promiscuous kinase inhibitors into safer drugs.

Zhang X, Crespo A, Fernández A.

Trends Biotechnol. 2008 Jun;26(6):295-301. doi: 10.1016/j.tibtech.2008.02.008. Epub 2008 Apr 9. Review.

PMID:
18403035
5.

Biological effects and mechanism of action of farnesyl transferase inhibitors.

Ashar HR, Armstrong L, James LJ, Carr DM, Gray K, Taveras A, Doll RJ, Bishop WR, Kirschmeier PT.

Chem Res Toxicol. 2000 Oct;13(10):949-52. Review. No abstract available.

PMID:
11080039
6.

Chemistry and pharmacology of collinin, active principle of Zanthoxylum spp.

Epifano F, Genovese S, Marcotullio MC, Curini M.

Mini Rev Med Chem. 2008 Oct;8(12):1203-8. Review.

PMID:
18855734
7.

Inhibitors of glutamine synthetase and their potential application in medicine.

Berlicki Ł.

Mini Rev Med Chem. 2008 Aug;8(9):869-78. Review.

PMID:
18691144
8.

Current progress on farnesyl protein transferase inhibitors.

Singh SB, Lingham RB.

Curr Opin Drug Discov Devel. 2002 Mar;5(2):225-44. Review.

PMID:
11926129
9.

Targeting the RAS signaling pathway in malignant hematologic diseases.

Morgan MA, Ganser A, Reuter CW.

Curr Drug Targets. 2007 Feb;8(2):217-35. Review.

PMID:
17305500
10.

Recent developments in isocyanide based multicomponent reactions in applied chemistry.

Dömling A.

Chem Rev. 2006 Jan;106(1):17-89. Review. No abstract available.

PMID:
16402771
11.

Cinnamic acid derivatives as anticancer agents-a review.

De P, Baltas M, Bedos-Belval F.

Curr Med Chem. 2011;18(11):1672-703. Review.

PMID:
21434850
12.
13.

The IC(50) concept revisited.

Caldwell GW, Yan Z, Lang W, Masucci JA.

Curr Top Med Chem. 2012;12(11):1282-90. Review.

PMID:
22571790
14.

Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics.

Gelb MH, Van Voorhis WC, Buckner FS, Yokoyama K, Eastman R, Carpenter EP, Panethymitaki C, Brown KA, Smith DF.

Mol Biochem Parasitol. 2003 Feb;126(2):155-63. Review.

PMID:
12615314
15.

[The optimization of bioactive lead structures. III. Verification of the system].

Mager PP.

Pharm Unserer Zeit. 1988 Nov;17(6):177-88. Review. German. No abstract available.

PMID:
3070576
16.

[Natural coumarins. II].

Nikonov GK.

Aptechn Delo. 1965 May-Jun;14(3):62-70. Review. Russian. No abstract available.

PMID:
5327334

Supplemental Content

Support Center